BetterScholar BetterScholar
11
Role
Title
Level Year L/R
🐜 Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria.
16 auth. M. Flowers, Y. Inamoto, P. Carpenter, Stephanie J. Lee, H. Kiem, E. Petersdorf, S. Pereira, R. Nash, M. Mielcarek, M. Fero, ... E. Warren, J. Sanders, R. Storb, F. Appelbaum, B. Storer, P. Martin
9 2011
9
🐜
🐒 First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation.
13 auth. P. Martin, J. D. Rizzo, J. Wingard, K. Ballen, P. Curtin, C. Cutler, M. Litzow, Y. Nieto, B. Savani, J. Schriber, ... P. Shaughnessy, D. Wall, P. Carpenter
9 2012
9
🐒
🐬 Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality.
A. Upton, K. Kirby, P. Carpenter, M. Boeckh, K. Marr
9 2007
9
🐬
🐜 Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation.
15 auth. N. Majhail, Stephanie Farnia, P. Carpenter, R. Champlin, S. Crawford, D. Marks, J. Omel, P. Orchard, J. Palmer, W. Saber, ... B. Savani, P. Veys, C. Bredeson, S. Giralt, C. LeMaistre
8 2015
8
🐜
🐜 Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report.
31 auth. D. Couriel, P. Carpenter, C. Cutler, J. BolaΓ±os-Meade, N. Treister, J. Gea-Banacloche, P. Shaughnessy, S. Hymes, Stella K. Kim, A. Wayne, J. Chien, J. Neumann, S. Mitchell, K. Syrjala, C. Moravec, ... L. Abramovitz, J. Liebermann, A. Berger, L. Gerber, M. Schubert, A. Filipovich, D. Weisdorf, M. Schubert, H. Shulman, K. Schultz, B. Mittelman, S. Pavletic, G. Vogelsang, P. Martin, Stephanie J. Lee, M. Flowers
8 2006
8
🐜
🐜 Duration of immunosuppressive treatment for chronic graft-versus-host disease.
17 auth. B. Stewart, B. Storer, J. Storek, H. Deeg, R. Storb, J. Hansen, F. Appelbaum, P. Carpenter, J. Sanders, H. Kiem, ... R. Nash, E. Petersdorf, C. Moravec, A. Morton, C. Anasetti, M. Flowers, P. Martin
8 2004
8
🐜
🐜 Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD.
12 auth. A. Vigorito, P. Campregher, B. Storer, P. Carpenter, C. Moravec, H. Kiem, ... M. Fero, E. Warren, Stephanie J. Lee, F. Appelbaum, P. Martin, M. Flowers
7 2009
7
🐜
🦁 Prophylactic administration of imatinib after hematopoietic cell transplantation for high-risk Philadelphia chromosome-positive leukemia.
8 auth. P. Carpenter, D. Snyder, M. Flowers, J. Sanders, T. Gooley, P. Martin, ... F. Appelbaum, J. Radich
7 2007
7
🦁
🐒 Peripheral blood progenitor cell mobilization for autologous and allogeneic hematopoietic cell transplantation: guidelines from the American Society for Blood and Marrow Transplantation.
17 auth. H. Duong, B. Savani, E. Copelan, S. Devine, L. Costa, J. Wingard, P. Shaughnessy, N. Majhail, M. Perales, C. Cutler, ... W. Bensinger, M. Litzow, M. Mohty, R. Champlin, H. Leather, S. Giralt, P. Carpenter
7 2014
7
🐒
🐜 Posttransplantation cyclophosphamide for prevention of graft-versus-host disease after HLA-matched mobilized blood cell transplantation.
10 auth. M. Mielcarek, T. Furlong, P. O'Donnell, B. Storer, J. McCune, R. Storb, ... P. Carpenter, Mary E. D. Flowers, F. Appelbaum, P. Martin
7 2016
7
🐜
🦁 National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report.
22 auth. P. Carpenter, C. Kitko, S. Elad, M. Flowers, J. Gea-Banacloche, J. Halter, F. Hoodin, L. Johnston, A. Lawitschka, G. McDonald, ... A. Opipari, B. Savani, K. Schultz, Sean R. Smith, K. Syrjala, N. Treister, G. Vogelsang, K. Williams, S. Pavletic, P. Martin, Stephanie J. Lee, D. Couriel
7 2015
7
🦁